Characterization of nano oxaliplatin prepared by novel Fat Employing Supercritical Nano System, the FESNS^®

References

• Hall S, Bradley T, Moore JT, Kuykindall T, Minella L. Acute and chronic toxicity of nano-scale TiO2 particles to freshwater fish, cladocerans, and green algae, and effects of organic and inorganic substrate on TiO2 toxicity. Nanotoxicology 2009;3:91–97.
   Web of Science ®Google Scholar
• Powers KW, Palazuelos M, Moudgil BM, Roberts SM. Characterization of the size, shape, and state of dispersion of nanoparticles for toxicological studies. Nanotoxicology 2007;1:42–51.
   Web of Science ®Google Scholar
• Lisa BP. Recent advances on the use of biodegradable microparticles and nanoparticles in controlled drug delivery. Int J Pharm 1995;116:1–9.
   Google Scholar
• Asgharian B, Price OT. Deposition of ultrafine (NANO) particles in the human lung. Inhalat Toxicol 2007;19:1045–1054.
   PubMed Web of Science ®Google Scholar
• Khosro A, Mohammad RSS, Ali N, Alireza J, Mohammad BJ, Jaleh B, Ghobad M, Yadollah O. Piroxicam nanoparticles for ocular delivery: Physicochemical characterization and implementation in endotoxin-induced uveitis. J Drug Target 2007;15:407–416.
   PubMed Web of Science ®Google Scholar
• Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release 2001;70:1–20.
   PubMed Web of Science ®Google Scholar
• Kruis FE, Joshi RK. Nanoparticle design and handling – challenges for engineers and particle technologists. China Particuol 2005;3:99–104.
   Google Scholar
• Gelperina S, Kisich K, Iseman MD, Heifets L. The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis. Am J Respir Crit Care Med 2005;172:1487–1490.
   PubMed Web of Science ®Google Scholar
• Mouritsen OG, Jorgensen K. Micro-, nano- and meso-scale heterogeneity of lipid bilayers and its influence on macroscopic membrane properties. Mol Mem Biology 1995;12:15–20.
   PubMed Web of Science ®Google Scholar
• Singh R, Lillard JW Jr. Nanoparticle-based targeted drug delivery. Exp Mol Pathol 2009;86: 215–223.
   PubMed Web of Science ®Google Scholar
• Kim MS, Jin SJ, Kim JS, Park HJ, Song HS, Neubert RHH, et al. Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process. Eur J Pharm Biopharm 2008;69:454–465.
   PubMed Web of Science ®Google Scholar
• Fages J, Lochard H, Letourneau J-J, Sauceau M, Rodier E. Particle generation for pharmaceutical applications using supercritical fluid technology. Powder Technology 2004;141: 219–226.
   Web of Science ®Google Scholar
• Wang H, Zhang J, Yu H. Elemental selenium at nano size possesses lower toxicity without compromising the fundamental effect on selenoenzymes: Comparison with selenomethionine in mice. Free Radic Biol Med 2007;42:1524–1533.
   PubMed Web of Science ®Google Scholar
• Leroux JC, Allèmann E, Jaeghere F, Doelker E, Gurny R. Biodegradable nanoparticles – from sustained release formulations to improved site-specific drug delivery. J Control Release 1996;39:339–350.
   Web of Science ®Google Scholar
• Rasenack N, Müller BW. Micron-size drug particles: Common and novel micronization techniques. Pharm Dev Technol 2004;9:1–13.
   PubMed Web of Science ®Google Scholar
• Hu J, Johnston KP, Williams III RO. Nanoparticle engineering processes for enhancing the dissolution rates of poorly water soluble drugs. Drug Dev Ind Pharm 2004;30:233–245.
   PubMed Web of Science ®Google Scholar
• Görner T, Gref R, Michenot D, Sommer F, Tran MN, Dellacherie E. Lidocaine-loaded biodegradable nanospheres. I. Optimization of the drug incorporation into the polymer matrix. J Control Release 1999;57:259–268.
   PubMed Web of Science ®Google Scholar
• Sharma P, Denny WA, Garg S. Effect of wet milling process on the solid state of indomethacin and simvastatin. Int J Pharm 2009;380:40–48.
   PubMed Web of Science ®Google Scholar
• Kipp JE. The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs. Int J Pharm 2004;284:109–122.
   PubMed Web of Science ®Google Scholar
• Cansell F, Aymonier C. Design of functional nanostructured materials using supercritical fluids. J Supercrit Fluids 2009;47:508–516.
   Web of Science ®Google Scholar
• Sacha GA, Schmitt WJ, Nail SL. Identification of critical process variables affecting particle size following precipitation using a supercritical fluid. Pharm Dev Technol 2006;11:187–194.
   PubMed Web of Science ®Google Scholar
• Tan HS, Borsadia S. Particle formation using supercritical fluids: Pharmaceutical applications. Exp Opin Ther Patents 2001;11:861–872.
   Web of Science ®Google Scholar
• Reverchon E, Adami R. Nanomaterials and supercritical fluids. J Supercrit Fluids 2006;37:1–22.
   Web of Science ®Google Scholar
• Sánchez-Vicente Y, Cabañas A, Renuncio JAR, Pando C. Supercritical fluid extraction of peach (Prunus persica) seed oil using carbon dioxide and ethanol. J Supercrit Fluids 2009;49:167–173.
   Web of Science ®Google Scholar
• Ye X, Wai CM. Making nanomaterials in supercritical fluids: A review. J Chem Educ 2003; 80:198–204.
   Web of Science ®Google Scholar
• Yeo SD, Kirana E. Formation of polymer particles with supercritical fluids: A review. J Supercrit Fluids 2005;34:287–308.
   Web of Science ®Google Scholar
• Jung J, Perrut M. Particle design using supercritical fluids: Literature and patent survey. J Supercrit Fluids 2001;20:179–219.
   Web of Science ®Google Scholar
• Temelli F. Perspectives on supercritical fluid processing of fats and oils. J Supercrit Fluids 2009;47:583–590.
   Web of Science ®Google Scholar
• Carrato A, Gallego J, Díaz-Rubio E. Oxaliplatin: Results in colorectal carcinoma. Crit Rev Oncol Hematol 2002;44:29–44.
   PubMed Web of Science ®Google Scholar
• Misset JL, Bleiberg H, Sutherland W, Bekradda M, Cvitkovic E. Oxaliplatin clinical activity: A review. Crit Rev Oncol Hematol 2000;35:75–93.
   PubMed Web of Science ®Google Scholar
• Jacobs C, Muller RH. Production and characterization of a budesonide nanosuspension for pulmonary administration. Pharm Res 2002;19:189–194.
   PubMed Web of Science ®Google Scholar
• Malich G, Markovic B, Winder C. The sensitivity and specificity of the MTS tetrazolium assay for detecting the in vitro cytotoxicity of 20 chemicals using human cell lines. Toxicology 1997;124:179–192.
   PubMed Web of Science ®Google Scholar
• Mahesh DC, Yogesh P, Jayanth P. Susceptibility of nanoparticle-encapsulated paclitaxel to P-glycoprotein-mediated drug efflux. Int J Pharm 2006;320:150–156.
   PubMed Web of Science ®Google Scholar
• Yogesh BP, Udaya ST, Ayman K, Linan M, Jayanth P. Single-step surface functionalization of polymeric nanoparticles for targeted drug delivery. Biomaterials 2009;30:859–866.
   PubMed Web of Science ®Google Scholar